{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:32Z","timestamp":1791928892228,"version":"4.3.4"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yebeh.2026.111098","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:51:52Z","timestamp":1779270712000},"page":"111098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["SYNGAP1-related disorder: pathophysiology, epilepsy, cognitive and behavioral phenotypes, and precision therapeutic approaches"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5154-8717","authenticated-orcid":false,"given":"Debopam","family":"Samanta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.111098_b0005","unstructured":"Holder JL, Jr., Hamdan FF, Michaud JL. SYNGAP1-Related Intellectual Disability. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(\u00ae). Seattle (WA): University of Washington, Seattle Copyright \u00a9 1993-2026, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"key":"10.1016\/j.yebeh.2026.111098_b0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa0805392","article-title":"Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation","volume":"360","author":"Hamdan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2026.111098_b0015","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1212\/WNL.0000000000006729","article-title":"SYNGAP1 encephalopathy: a distinctive generalized developmental and epileptic encephalopathy","volume":"92","author":"Vlaskamp","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111098_b0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/humu.22248","article-title":"Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency","volume":"34","author":"Berryer","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.yebeh.2026.111098_b0025","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1523\/JNEUROSCI.0420-19.2020","article-title":"Twenty years of SynGAP research: from synapses to cognition","volume":"40","author":"Gamache","year":"2020","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0030","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ng.2646","article-title":"Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1","volume":"45","author":"Carvill","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.yebeh.2026.111098_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101419","article-title":"Clinical signatures of SYNGAP1-related disorders through data integration","volume":"27","author":"McKee","year":"2025","journal-title":"Genet Med"},{"key":"10.1016\/j.yebeh.2026.111098_b0040","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.1523\/JNEUROSCI.1367-20.2020","article-title":"SYNGAP1 controls the maturation of dendrites, synaptic function, and network activity in developing human neurons","volume":"40","author":"Llamosas","year":"2020","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0045","doi-asserted-by":"crossref","unstructured":"Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017;542: 433-438.","DOI":"10.1038\/nature21062"},{"key":"10.1016\/j.yebeh.2026.111098_b0050","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cell.2012.08.045","article-title":"Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses","volume":"151","author":"Clement","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.yebeh.2026.111098_b0055","article-title":"Camkii-mediated phosphorylation regulates distributions of syngap-\u03b11 and -\u03b12 at the postsynaptic density","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2026.111098_b0060","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1074\/jbc.M114.614420","article-title":"Phosphorylation of synaptic GTPase-activating protein (synGAP) by Ca2+\/calmodulin-dependent protein kinase II (CaMKII) and cyclin-dependent kinase 5 (CDK5) alters the ratio of its GAP activity toward Ras and Rap GTPases","volume":"290","author":"Walkup","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yebeh.2026.111098_b0065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56273","article-title":"SynGAP isoforms differentially regulate synaptic plasticity and dendritic development","volume":"9","author":"Araki","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.yebeh.2026.111098_b0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0896-6273(00)81008-9","article-title":"SynGAP: a synaptic RasGAP that associates with the PSD-95\/SAP90 protein family","volume":"20","author":"Kim","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.yebeh.2026.111098_b0075","article-title":"A model for regulation by SynGAP-\u03b11 of binding of synaptic proteins to PDZ-domain 'Slots' in the postsynaptic density","volume":"5","author":"Walkup","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.yebeh.2026.111098_b0080","doi-asserted-by":"crossref","first-page":"rs8","DOI":"10.1126\/scisignal.aaf6716","article-title":"Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome","volume":"9","author":"Li","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.yebeh.2026.111098_b0085","doi-asserted-by":"crossref","first-page":"13673","DOI":"10.1523\/JNEUROSCI.4695-08.2008","article-title":"SynGAP regulates steady-state and activity-dependent phosphorylation of cofilin","volume":"28","author":"Carlisle","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuroscience.2011.06.061","article-title":"SynGAP moves out of the core of the postsynaptic density upon depolarization","volume":"192","author":"Yang","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2026.111098_b0095","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cell.2016.07.008","article-title":"Phase transition in postsynaptic densities underlies formation of synaptic complexes and synaptic plasticity","volume":"166","author":"Zeng","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.yebeh.2026.111098_b0100","first-page":"296","article-title":"Anchoring high concentrations of SynGAP at postsynaptic densities via liquid-liquid phase separation","volume":"10","author":"Zeng","year":"2019","journal-title":"Small GTPases"},{"key":"10.1016\/j.yebeh.2026.111098_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2023.103132","article-title":"Generation of a transgene-free iPS cell line (SDQLCHi053-a) from a young girl carrying a heterozygous mutation (c.427C>T) in SYNGAP1 gene","volume":"71","author":"Wang","year":"2023","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.yebeh.2026.111098_b0110","doi-asserted-by":"crossref","unstructured":"Stamenkovic V, Harsh F, Kniffen B, Rumbaugh G, Smith S. Genetic rescue of disrupted synaptic protein interaction network dynamics following SYNGAP1 reactivation. bioRxiv 2025.","DOI":"10.64898\/2025.12.02.691969"},{"key":"10.1016\/j.yebeh.2026.111098_b0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuron.2014.12.023","article-title":"Rapid dispersion of SynGAP from synaptic spines triggers AMPA receptor insertion and spine enlargement during LTP","volume":"85","author":"Araki","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.yebeh.2026.111098_b0120","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/jnc.14988","article-title":"SynGAP splice variants display heterogeneous spatio-temporal expression and subcellular distribution in the developing mammalian brain","volume":"154","author":"Gou","year":"2020","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2026.111098_b0125","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.biopsych.2014.08.001","article-title":"Syngap1 haploinsufficiency damages a postnatal critical period of pyramidal cell structural maturation linked to cortical circuit assembly","volume":"77","author":"Aceti","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2026.111098_b0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100579118","article-title":"Syngap1 regulates experience-dependent cortical ensemble plasticity by promoting in vivo excitatory synapse strengthening","volume":"118","author":"Llamosas","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.yebeh.2026.111098_b0135","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.pharep.2018.02.021","article-title":"Chronic treatment with a MEK inhibitor reverses enhanced excitatory field potentials in Syngap1(+\/-) mice","volume":"70","author":"Kopanitsa","year":"2018","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.yebeh.2026.111098_b0140","doi-asserted-by":"crossref","DOI":"10.1177\/26331055241235921","article-title":"A vascular-centric approach to autism spectrum disorders","volume":"19","author":"Ouellette","year":"2024","journal-title":"Neurosci Insights"},{"key":"10.1016\/j.yebeh.2026.111098_b0145","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk1291","article-title":"SynGAP regulates synaptic plasticity and cognition independently of its catalytic activity","volume":"383","author":"Araki","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.yebeh.2026.111098_b0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00221-021-06254-x","article-title":"Pharmacological intervention in young adolescents rescues synaptic physiology and behavioural deficits in Syngap1(+\/-) mice","volume":"240","author":"Verma","year":"2022","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.yebeh.2026.111098_b0155","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.biopsych.2019.12.025","article-title":"Low-Dose perampanel rescues cortical gamma dysregulation associated with parvalbumin interneuron GluA2 upregulation in Epileptic Syngap1(+\/-) mice","volume":"87","author":"Sullivan","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2026.111098_b0160","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41467-025-56125-0","article-title":"Syngap1 promotes cognitive function through regulation of cortical sensorimotor dynamics","volume":"16","author":"Vaissiere","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.yebeh.2026.111098_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41593-018-0268-0","article-title":"SYNGAP1 heterozygosity disrupts sensory processing by reducing touch-related activity within somatosensory cortex circuits","volume":"21","author":"Michaelson","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0170","doi-asserted-by":"crossref","first-page":"13340","DOI":"10.1038\/ncomms13340","article-title":"Decrease of SYNGAP1 in GABAergic cells impairs inhibitory synapse connectivity, synaptic inhibition and cognitive function","volume":"7","author":"Berryer","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.yebeh.2026.111098_b0175","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1523\/JNEUROSCI.1997-22.2023","article-title":"Interneuron-targeted disruption of SYNGAP1 alters sensory representations in the neocortex and impairs sensory learning","volume":"43","author":"Zhao","year":"2023","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0180","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0946-24.2024","article-title":"Developmental Syngap1 haploinsufficiency in medial ganglionic eminence-derived interneurons impairs auditory cortex activity, social behavior, and extinction of fear memory","volume":"44","author":"Jadhav","year":"2024","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0185","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/brain\/awab329","article-title":"Sensory processing dysregulations as reliable translational biomarkers in SYNGAP1 haploinsufficiency","volume":"145","author":"Carre\u00f1o-Mu\u00f1oz","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2026.111098_b0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.97100.4","article-title":"Syngap1 regulates the synaptic drive and membrane excitability of Parvalbumin-positive interneurons in mouse auditory cortex","volume":"13","author":"Francavilla","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.yebeh.2026.111098_b0195","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s13023-025-03918-7","article-title":"Analysis of retrospective natural history data collected from patients with SYNGAP1-related disorders: a preliminary examination of the Citizen database","volume":"20","author":"Scott","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.yebeh.2026.111098_b0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jmedgenet-2015-103451","article-title":"Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy","volume":"53","author":"Mignot","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.yebeh.2026.111098_b0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s11689-019-9276-y","article-title":"Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression","volume":"11","author":"Jimenez-Gomez","year":"2019","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.yebeh.2026.111098_b0210","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/epi.17913","article-title":"Comprehensive phenotypes of patients with SYNGAP1-related disorder reveals high rates of epilepsy and autism","volume":"65","author":"Wiltrout","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111098_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.761473","article-title":"Phenotypes in Children with SYNGAP1 Encephalopathy in China","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0220","unstructured":"Pierce SR, Orlando JM, Cunningham KG, Ruggiero SM, McKee JL, Helbig I. Reliability and Stability of Cerebral Palsy Classification Scales for Individuals with STXBP1 Related Disorders and SYNGAP1 Related Disorders. medRxiv 2025."},{"key":"10.1016\/j.yebeh.2026.111098_b0225","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63606","article-title":"SYNGAP1-related developmental and epileptic encephalopathy: genotypic and phenotypic characteristics and longitudinal insights","volume":"194","author":"Kim","year":"2024","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.yebeh.2026.111098_b0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s11689-024-09563-8","article-title":"Behavioural and neurodevelopmental characteristics of SYNGAP1","volume":"16","author":"Bednarczuk","year":"2024","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.yebeh.2026.111098_b0235","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/ajmg.a.37189","article-title":"De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability","volume":"167a","author":"Parker","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.yebeh.2026.111098_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2022.918918","article-title":"Comparison of treadmill gait between a Pediatric-aged individual with SYNGAP1-related intellectual disability and a fraternal twin","volume":"16","author":"Layne","year":"2022","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12881-017-0425-4","article-title":"Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report","volume":"18","author":"Prchalova","year":"2017","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.yebeh.2026.111098_b0250","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200105","article-title":"Adult phenotype of SYNGAP1-DEE","volume":"9","author":"Rong","year":"2023","journal-title":"Neurol Genet"},{"key":"10.1016\/j.yebeh.2026.111098_b0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1352\/1944-7558-129.3.199","article-title":"The behavioral profile of SYNGAP1-related intellectual disability","volume":"129","author":"Wright","year":"2024","journal-title":"Am J Intellect Dev Disabil"},{"key":"10.1016\/j.yebeh.2026.111098_b0260","article-title":"Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy. Front Cell","volume":"12","author":"Ribeiro-Constante","year":"2024","journal-title":"Dev Biol"},{"key":"10.1016\/j.yebeh.2026.111098_b0265","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1111\/j.1528-1167.2011.03304.x","article-title":"A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA)","volume":"52","author":"Klitten","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111098_b0270","article-title":"Unveiling a de novo SYNGAP1 variant: Clinical progression and management challenges in a case of developmental and epileptic encephalopathy - a case report","volume":"12","author":"de Le\u00f3n Ojeda","year":"2024","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.yebeh.2026.111098_b0275","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0035-1554098","article-title":"SYNGAP1 mutation in focal and generalized epilepsy: a literature overview and a case report with special aspects of the EEG","volume":"46","author":"von St\u00fclpnagel","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2026.111098_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110472","article-title":"Seizure-type-specific treatment responses in Lennox-Gastaut Syndrome: a comprehensive review of pharmacological, neuromodulatory, dietary, and surgical therapies","volume":"170","author":"Samanta","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111098_b0285","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/acn3.52211","article-title":"Clinical trials for Lennox-Gastaut syndrome: challenges and priorities","volume":"11","author":"Knowles","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.yebeh.2026.111098_b0290","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.seizure.2018.12.020","article-title":"Chewing induced reflex seizures (\u201ceating epilepsy\u201d) and eye closure sensitivity as a common feature in pediatric patients with SYNGAP1 mutations: Review of literature and report of 8 cases","volume":"65","author":"von St\u00fclpnagel","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.111098_b0295","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.clinph.2021.01.014","article-title":"SYNGAP1-DEE: a visual sensitive epilepsy","volume":"132","author":"Lo Barco","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2026.111098_b0300","first-page":"1059","volume":"59","author":"Tian","year":"2021","journal-title":"Deng J Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.yebeh.2026.111098_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.957915","article-title":"Phenotype and genotype analyses of chinese patients with autosomal dominant mental retardation type 5 caused by SYNGAP1 gene mutations","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.yebeh.2026.111098_b0310","first-page":"489","volume":"25","author":"Wang","year":"2023","journal-title":"Peng J Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.yebeh.2026.111098_b0315","first-page":"25","article-title":"Correlation of early neurodevelopmental features of children with SYNGAP1 variants and their genotypes","volume":"41","author":"Liu","year":"2024","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"10.1016\/j.yebeh.2026.111098_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108500","article-title":"SYNGAP1-related developmental and epileptic encephalopathy: the impact on daily life","volume":"127","author":"Lo Barco","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111098_b0325","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijdevneu.2019.08.003","article-title":"SYNGAP1 mutations: clinical, genetic, and pathophysiological features","volume":"78","author":"Agarwal","year":"2019","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0330","doi-asserted-by":"crossref","first-page":"e1712","DOI":"10.1212\/WNL.0000000000207080","article-title":"Rates of status epilepticus and sudden unexplained death in epilepsy in people with genetic developmental and epileptic encephalopathies","volume":"100","author":"Donnan","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111098_b0335","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.c.32058","article-title":"Development of webcam-collected and artificial-intelligence-derived social and cognitive performance measures for neurodevelopmental genetic syndromes","volume":"193","author":"Frazier","year":"2023","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.yebeh.2026.111098_b0340","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/aur.3148","article-title":"Visual social attention in SYNGAP1-related intellectual disability","volume":"17","author":"Wright","year":"2024","journal-title":"Autism Res"},{"key":"10.1016\/j.yebeh.2026.111098_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109584","article-title":"Severe behavior problems in SYNGAP1-related disorder: a summary of 11 consecutive patients in a tertiary care specialty clinic","volume":"150","author":"Thomas","year":"2024","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111098_b0350","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/jir.13145","article-title":"Behavioural phenotype of SYNGAP1-related intellectual disability","volume":"68","author":"Kranak","year":"2024","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.yebeh.2026.111098_b0355","article-title":"Sensory processing phenotypes in Phelan-McDermid syndrome and SYNGAP1-related intellectual disability","volume":"12","author":"Lyons-Warren","year":"2022","journal-title":"BrainSci"},{"key":"10.1016\/j.yebeh.2026.111098_b0360","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neubiorev.2019.04.022","article-title":"Genetic mechanisms of regression in autism spectrum disorder","volume":"102","author":"Tammimies","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.yebeh.2026.111098_b0365","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.clinph.2021.03.054","article-title":"Differential auditory brain response abnormalities in two intellectual disability conditions: SYNGAP1 mutations and down syndrome","volume":"132","author":"C\u00f4t\u00e9","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2026.111098_b0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s11689-022-09437-x","article-title":"Clinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description","volume":"14","author":"Wright","year":"2022","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.yebeh.2026.111098_b0375","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10803-023-06162-9","article-title":"Profiling autism and attention deficit hyperactivity disorder traits in children with SYNGAP1-related intellectual disability","volume":"55","author":"Wright","year":"2025","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2026.111098_b0380","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pediatrneurol.2025.05.017","article-title":"SYNGAP1-related intellectual disability: meaningful clinical outcomes and development of a disease concept model draft","volume":"169","author":"Cunnane","year":"2025","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111098_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1401746","article-title":"Context-dependent hyperactivity in syngap1a and syngap1b zebrafish models of SYNGAP1-related disorder","volume":"17","author":"Sumathipala","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0390","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/cap.2024.0055","article-title":"SYNGAP-1 mutation and catatonia: a case series and systematic review","volume":"34","author":"Baldwin","year":"2024","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.yebeh.2026.111098_b0395","article-title":"Sleep abnormalities in the synaptopathies-SYNGAP1-related intellectual disability and Phelan-McDermid syndrome","volume":"11","author":"Smith-Hicks","year":"2021","journal-title":"BrainSci"},{"key":"10.1016\/j.yebeh.2026.111098_b0400","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1007\/s10803-025-07069-3","article-title":"Characterizing key correlates of sleep problems across rare neurodevelopmental genetic disorders","volume":"55","author":"Baker","year":"2025","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2026.111098_b0405","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.5664\/jcsm.11246","article-title":"Subjective sleep assessment in individuals with SYNGAP1-associated syndrome","volume":"20","author":"Mosini","year":"2024","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.yebeh.2026.111098_b0410","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.sleep.2023.04.008","article-title":"An exploratory study of sleep quality and quantity in children with causal variants in SYNGAP1, an autism risk gene","volume":"107","author":"Paasch","year":"2023","journal-title":"Sleep Med"},{"key":"10.1016\/j.yebeh.2026.111098_b0415","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s10803-021-05030-8","article-title":"Health-related quality of life in pediatric patients with syndromic autism and their caregivers","volume":"52","author":"Bolbocean","year":"2022","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2026.111098_b0420","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ejhg.2010.172","article-title":"Integrated analysis of clinical signs and literature data for the diagnosis and therapy of a previously undescribed 6p21.3 deletion syndrome","volume":"19","author":"Zollino","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.yebeh.2026.111098_b0425","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/labmed\/lmad064","article-title":"Molecular and phenotypical findings of a novel de novo SYNGAP1 gene variant in an 11-year-old iranian boy with intellectual disability","volume":"55","author":"Mir","year":"2024","journal-title":"Lab Med"},{"key":"10.1016\/j.yebeh.2026.111098_b0430","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/cga.12273","article-title":"Novel SYNGAP1 variant in a patient with intellectual disability and distinctive dysmorphisms","volume":"58","author":"Kimura","year":"2018","journal-title":"Congenit Anom (Kyoto)"},{"key":"10.1016\/j.yebeh.2026.111098_b0435","doi-asserted-by":"crossref","DOI":"10.3390\/pediatric17060127","article-title":"Two rare cases of bilateral diaphragmatic paralysis in neonates","volume":"17","author":"Ronci","year":"2025","journal-title":"Pediatr Rep"},{"key":"10.1016\/j.yebeh.2026.111098_b0440","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/a-2749-5951","article-title":"Compulsive respiratory stereotypies in a patient with SYNGAP1 mutation","volume":"57","author":"Hartlieb","year":"2026","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2026.111098_b0445","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ejpn.2019.04.006","article-title":"The most recurrent monogenic disorders that overlap with the phenotype of Rett syndrome","volume":"23","author":"Vidal","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111098_b0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258766","article-title":"New genes involved in Angelman syndrome-like: expanding the genetic spectrum","volume":"16","author":"Aguilera","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2026.111098_b0455","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MCD.0000000000000280","article-title":"Dual diagnosis causing severe phenotype in a patient with Angelman syndrome","volume":"28","author":"Kanani","year":"2019","journal-title":"Clin Dysmorphol"},{"key":"10.1016\/j.yebeh.2026.111098_b0460","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1671464","article-title":"De novo frameshift mutation in SYNGAP1 resulting in autosomal dominant mental retardation type 5 and autism spectrum disorder: a case report","volume":"13","author":"Lin","year":"2025","journal-title":"Front Pediatr"},{"key":"10.1016\/j.yebeh.2026.111098_b0465","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214148","article-title":"Quantitative EEG biomarkers in the genetic epilepsies and associations with neurologic outcomes","volume":"105","author":"Galer","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111098_b0470","first-page":"1","article-title":"Detrended fluctuation analysis to assess long-range temporal correlations in EEG from SYNGAP1-related disorder","volume":"2025","author":"Tasnia","year":"2025","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.yebeh.2026.111098_b0475","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.70066","article-title":"Novel de novo intronic Variant of SYNGAP1 associated with the neurodevelopmental disorders","volume":"13","author":"Xie","year":"2025","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.yebeh.2026.111098_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114733","article-title":"Key roles of C2\/GAP domains in SYNGAP1-related pathophysiology","volume":"43","author":"Katsanevaki","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.yebeh.2026.111098_b0485","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1111\/epi.18469","article-title":"Familial SYNGAP1 variants define the boundaries of a complex neurodevelopmental disorder with epilepsy","volume":"66","author":"Harrison","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111098_b0490","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cge.14661","article-title":"Genotype-phenotype correlations in SYNGAP1-related mental retardation type 5","volume":"107","author":"Hong","year":"2025","journal-title":"Clin Genet"},{"key":"10.1016\/j.yebeh.2026.111098_b0495","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000529408","article-title":"Novel SYNGAP1 variant in an adult individual affected by intellectual disability and epilepsy: a cold case solved through whole-exome sequencing","volume":"14","author":"Rosti","year":"2023","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.yebeh.2026.111098_b0500","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/humu.23699","article-title":"Reanalysis and optimisation of bioinformatic pipelines is critical for mutation detection","volume":"40","author":"Cowley","year":"2019","journal-title":"Hum Mutat"},{"key":"10.1016\/j.yebeh.2026.111098_b0505","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajhg.2020.11.011","article-title":"Multi-parametric analysis of 57 SYNGAP1 variants reveal impacts on GTPase signaling, localization, and protein stability","volume":"108","author":"Meili","year":"2021","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.yebeh.2026.111098_b0510","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1188117","article-title":"Social behavioral impairments in SYNGAP1-related intellectual disability","volume":"11","author":"Naveed","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.yebeh.2026.111098_b0515","article-title":"Sleep in lennox-gastaut syndrome: a scoping review","volume":"12","author":"Samanta","year":"2025","journal-title":"Children (Basel)"},{"key":"10.1016\/j.yebeh.2026.111098_b0520","article-title":"Roadmap to advance therapeutics for SYNGAP1-related disorder: a patient organization perspective from SynGAP Research Fund","volume":"6","author":"Graglia","year":"2025","journal-title":"Ther Adv Rare Dis"},{"key":"10.1016\/j.yebeh.2026.111098_b0525","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/epi.16508","article-title":"Phenotypic and genetic spectrum of epilepsy with myoclonic atonic seizures","volume":"61","author":"Tang","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111098_b0530","article-title":"Clinical and genetic landscape of epilepsies with absence seizures and single-gene etiology","author":"Balestrini","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111098_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.109636","article-title":"Atypical absence seizures and gene variants: a gene-based review of etiology, electro-clinical features, and associated epilepsy syndrome","volume":"151","author":"Zhao","year":"2024","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111098_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107147","article-title":"A comprehensive narrative review of epilepsy with eyelid myoclonia","volume":"193","author":"Smith","year":"2023","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111098_b0545","article-title":"Cognitive and behavioral impact of antiseizure medications, neuromodulation, ketogenic diet, and surgery in Lennox-Gastaut syndrome: a comprehensive review","volume":"164","author":"Samanta","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111098_b0550","article-title":"Antiseizure medications for Lennox-Gastaut Syndrome: comprehensive review and proposed consensus treatment algorithm","volume":"164","author":"Samanta","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111098_b0555","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.seizure.2025.11.016","article-title":"Efficacy and safety of cenobamate in developmental and epileptic encephalopathies: a systematic review and meta-analysis","volume":"134","author":"Samanta","year":"2026","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.111098_b0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110787","article-title":"Cenobamate in pediatric epilepsy and developmental and epileptic encephalopathies: efficacy, safety, and syndrome-specific considerations","volume":"173","author":"Samanta","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111098_b0565","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/epi4.12411","article-title":"Add-on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy","volume":"5","author":"Kuchenbuch","year":"2020","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111098_b0570","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-021-00807-y","article-title":"Highly purified cannabidiol for epilepsy treatment: a systematic review of epileptic conditions beyond dravet syndrome and lennox-gastaut syndrome","volume":"35","author":"Lattanzi","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2026.111098_b0575","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nrl.2023.01.002","article-title":"Epileptic and neurodevelopmental encephalopathy associated to SYNGAP1 mutation: Description of a case and treatment response to cannabidiol","volume":"39","author":"L\u00f3pez-Moreno","year":"2024","journal-title":"Neurologia (Engl Ed)"},{"key":"10.1016\/j.yebeh.2026.111098_b0580","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2019.03.014","article-title":"Cannabidiol: a review of clinical efficacy and safety in epilepsy","volume":"96","author":"Samanta","year":"2019","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111098_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2026.107731","article-title":"A systematic review of highly purified cannabidiol in developmental and epileptic encephalopathies and complex treatment-resistant epilepsies: changes in seizure frequency and adverse events","volume":"220","author":"Coppola","year":"2026","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111098_b0590","article-title":"A review of pharmacology, clinical efficacy, and safety in epilepsy","volume":"9","author":"Fenfluramine","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.yebeh.2026.111098_b0595","article-title":"Bexicaserin for the treatment of seizures in developmental and epileptic encephalopathies: a phase 1b\/2a trial (PACIFIC)","author":"Dlugos","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111098_b0600","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s42494-022-00114-z","article-title":"Novel variants of SYNGAP1 associated epileptic encephalopathy: two cases report and literature review","volume":"5","author":"Zeng","year":"2023","journal-title":"Acta Epileptol"},{"key":"10.1016\/j.yebeh.2026.111098_b0605","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1221161","article-title":"Case report: Off-label use of low-dose perampanel in a 25-month-old girl with a pathogenic SYNGAP1 variant","volume":"14","author":"Gupta","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2026.111098_b0610","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/epi.17530","article-title":"Perampanel as precision therapy in rare genetic epilepsies","volume":"64","author":"Nissenkorn","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111098_b0615","article-title":"Stiripentol, and ganaxolone in lennox-gastaut syndrome: a comprehensive narrative review","volume":"14","author":"Perampanel","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.yebeh.2026.111098_b0620","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pediatrneurol.2025.04.010","article-title":"Current and emerging precision therapies for developmental and epileptic encephalopathies","volume":"168","author":"Samanta","year":"2025","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111098_b0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094278","article-title":"Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway","volume":"9","author":"Huo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2026.111098_b0630","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/cap.2018.0159","article-title":"Lovastatin treatment of a patient with a De Novo SYNGAP1 protein truncating variant","volume":"29","author":"Cook","year":"2019","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.yebeh.2026.111098_b0635","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0039-1681066","article-title":"Positive short-term effect of low-dose rosuvastatin in a patient with SYNGAP1-associated epilepsy","volume":"50","author":"Kluger","year":"2019","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2026.111098_b0640","doi-asserted-by":"crossref","first-page":"9225","DOI":"10.1007\/s11033-020-05915-4","article-title":"Identification of an individual with a SYGNAP1 pathogenic mutation in India","volume":"47","author":"Verma","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.yebeh.2026.111098_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114799","article-title":"Immunoliposomes - a new therapeutic option to treat SynGAP1-associated epilepsy","volume":"214","author":"Wienken","year":"2025","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.yebeh.2026.111098_b0650","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/WNL.0000000000009009","article-title":"Reader response: SYNGAP1 encephalopathy: a distinctive generalized developmental and epileptic encephalopathy","volume":"94","author":"Fung","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111098_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2025.107641","article-title":"SYNGAP-1 developmental and epileptic encephalopathy: Utility of corpus callosotomy and neuromodulation","volume":"218","author":"DeGasperis","year":"2025","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111098_b0660","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/epi.17853","article-title":"A multi-center comparison of surgical techniques for corpus Callosotomy in pediatric drug-resistant epilepsy","volume":"65","author":"Hansen","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111098_b0665","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1111\/epi.18544","article-title":"Comparative efficacy of neuromodulation therapies in Lennox-Gastaut syndrome: a systematic review and meta-analysis of vagus nerve stimulation, deep brain stimulation, and responsive neurostimulation","volume":"66","author":"Samanta","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111098_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.110067","article-title":"Neuromodulation strategies in developmental and epileptic encephalopathies","volume":"160","author":"Samanta","year":"2024","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111098_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107499","article-title":"Neuromodulation strategies in lennox-gastaut syndrome: practical clinical guidance from the pediatric epilepsy research consortium","volume":"210","author":"Samanta","year":"2025","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111098_b0680","article-title":"Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders","volume":"54","author":"Marotta","year":"2024","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/j.yebeh.2026.111098_b0685","article-title":"Precision therapeutics in lennox-gastaut syndrome: targeting molecular pathophysiology in a developmental and epileptic encephalopathy","volume":"12","author":"Samanta","year":"2025","journal-title":"Children (Basel)"},{"key":"10.1016\/j.yebeh.2026.111098_b0690","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46752","article-title":"Re-expression of SynGAP protein in adulthood improves translatable measures of brain function and behavior","volume":"8","author":"Creson","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.yebeh.2026.111098_b0695","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.neuron.2014.05.015","article-title":"Reduced cognition in Syngap1 mutants is caused by isolated damage within developing forebrain excitatory neurons","volume":"82","author":"Ozkan","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.yebeh.2026.111098_b0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.110171","article-title":"A comprehensive review of evolving treatment strategies for Dravet syndrome: insights from randomized trials, meta-analyses, real-world evidence, and emerging therapeutic approaches","volume":"162","author":"Samanta","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111098_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.braindev.2026.104527","article-title":"Emerging disease-modifying therapies for Angelman syndrome: a comprehensive review for pediatric neurologists","volume":"48","author":"Samanta","year":"2026","journal-title":"Brain and Development"},{"key":"10.1016\/j.yebeh.2026.111098_b0710","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.624881","article-title":"Identification of natural antisense transcripts in mouse brain and their association with autism spectrum disorder risk genes","volume":"14","author":"Ko\u00e7","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0715","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1412964","article-title":"Splice-switching antisense oligonucleotides for pediatric neurological disorders","volume":"17","author":"Zhang","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.yebeh.2026.111098_b0720","unstructured":"Yeliz Yuva-Aydemir. CMP-SYNGAP-01: A Developmental Candidate Antisense Oligonucleotide Targeting a SYNGAP1 Regulatory RNA for the Potential Treatment of SYNGAP1-Related Disorders. American Epilepsy Society. 12\/8\/2005. https:\/\/aesnet.org\/abstractslisting\/cmp-syngap-01-a-developmental-candidate-antisense-oligonucleotide-targeting-a-syngap1-regulatory-rna-for-the-potential-treatment-of-syngap1-related-disorders. In."},{"key":"10.1016\/j.yebeh.2026.111098_b0725","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/ipm.12.04.12","article-title":"In conversation with Josh Mandel-Brehm","volume":"12","author":"Doherty","year":"2025","journal-title":"Inside Precision Medicine"},{"key":"10.1016\/j.yebeh.2026.111098_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2025.107621","article-title":"Phenylbutyrate for monogenetic epilepsy: Literature review","volume":"217","author":"Stone","year":"2025","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111098_b0735","doi-asserted-by":"crossref","unstructured":"Sichlinger L, Reilly MB, Arora S, Zhang S, Marotta N, Rodr\u00edguez-Acevedo KL, Hooks M, Czarnecki KS, Winter JJ, Waxman EA, Dungan LV, Hong I, Araki Y, Johnson R, Huganir RL, Pavani G, French DL, Davidson BL, Prosser BL, Heller EA. CRISPR-mediated transcriptional activation as a mutation-independent therapeutic strategy for SYNGAP1-related intellectual disability. bioRxiv 2025.","DOI":"10.1101\/2025.10.28.685100"},{"key":"10.1016\/j.yebeh.2026.111098_b0740","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.neuron.2023.02.021","article-title":"Upregulation of SYNGAP1 expression in mice and human neurons by redirecting alternative splicing","volume":"111","author":"Yang","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.yebeh.2026.111098_b0745","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/s41467-023-38273-3","article-title":"Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching","volume":"14","author":"Dawicki-McKenna","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.yebeh.2026.111098_b0750","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1038\/s41467-023-42252-z","article-title":"RNA-based translation activators for targeted gene upregulation","volume":"14","author":"Cao","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.yebeh.2026.111098_b0755","article-title":"Disease-modifying therapies for Rett syndrome: a review for neurologists","volume":"17","author":"Samanta","year":"2026","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2026.111098_b0760","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1016\/j.ymthe.2025.09.040","article-title":"AAV delivery of full-length SYNGAP1 rescues epileptic and behavioral phenotypes in a mouse model of SYNGAP1-related disorders","volume":"33","author":"Quinlan","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.yebeh.2026.111098_b0765","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75707","article-title":"Endogenous Syngap1 alpha splice forms promote cognitive function and seizure protection","volume":"11","author":"Kilinc","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.yebeh.2026.111098_b0770","doi-asserted-by":"crossref","first-page":"e3717","DOI":"10.1002\/jgm.3717","article-title":"Hematopoietic stem cell gene therapy for the treatment of SYNGAP1-related non-specific intellectual disability","volume":"26","author":"Anderson","year":"2024","journal-title":"J Gene Med"},{"key":"10.1016\/j.yebeh.2026.111098_b0775","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04533-3","article-title":"AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice","volume":"604","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2026.111098_b0780","unstructured":"CURESYNGAP1. $230K grant awarded to The Jackson Laboratory (JAX) to advance translational research on SYNGAP1-Related Disorders. https:\/\/www.eurekalert.org\/news-releases\/1066473[Internet] Accessed on April 16, 2026. In; 2024."},{"key":"10.1016\/j.yebeh.2026.111098_b0785","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14408","article-title":"Epigenetic modulation rescues neurodevelopmental deficits in Syngap1(+\/-) mice","volume":"24","author":"Singh","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.yebeh.2026.111098_b0790","doi-asserted-by":"crossref","DOI":"10.3390\/genes16040405","article-title":"SYNGAP1 syndrome and the brain gene registry","volume":"16","author":"Greco","year":"2025","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.yebeh.2026.111098_b0795","doi-asserted-by":"crossref","DOI":"10.1111\/cch.70215","article-title":"Daily care concerns among mothers of children with developmental and epileptic encephalopathies: a qualitative study using in-depth interviews","volume":"52","author":"Salcedo-Perez-Juana","year":"2026","journal-title":"Child Care Health Dev"},{"key":"10.1016\/j.yebeh.2026.111098_b0800","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1285377","article-title":"Quality of life, socioeconomic and psychological concerns in parents of children with tuberous sclerosis complex, STXBP1 and SYNGAP1 encephalopathies: a mixed method study","volume":"11","author":"Salcedo-Perez-Juana","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.yebeh.2026.111098_b0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110677","article-title":"A survey of adult caregivers of people with developmental and epileptic encephalopathies: a long-term care planning needs assessment","volume":"172","author":"Andrade","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111098_b0810","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52656","article-title":"A sex difference in the response of the rodent postsynaptic density to synGAP haploinsufficiency","volume":"9","author":"Mastro","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.yebeh.2026.111098_b0815","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.seizure.2015.02.012","article-title":"Interactions between hormones and epilepsy","volume":"28","author":"Taub\u00f8ll","year":"2015","journal-title":"Seizure"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026002192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026002192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:38:21Z","timestamp":1780544301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026002192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":163,"alternative-id":["S1525505026002192"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111098","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SYNGAP1-related disorder: pathophysiology, epilepsy, cognitive and behavioral phenotypes, and precision therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111098"}}